Shareholding disclosure

Yves Sagot

Declared position

9.89%

Threshold

Crossed upwards

Timeline

Published

14.11.2017

Transaction

09.11.2017

Voting rights breakdown

Voting rights acquired9.89%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAHBA00016

Beneficial owner

Yves Sagot

Declared address

Yves Sagot, 74160 Beaumont, France

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Yves Sagot

MindMaze Therapeutics Holding SA14.11.2017TAHBA00016

Disclosure summary

Yves Sagot disclosed a holding in MindMaze Therapeutics Holding SA on the acquisition side, published by SIX Exchange Regulation on 14.11.2017, at 9.89% of voting rights. Notice category: Single shareholder.

Disclosed position

9.89%

Voting rights acquired

Voting rights acquired9.89%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Yves Sagot disclosed a holding in MindMaze Therapeutics Holding SA, published on 14.11.2017.

Publication date14.11.2017

Transaction date09.11.2017

Issuing companyMindMaze Therapeutics Holding SA

Beneficial ownerYves Sagot

Declared addressYves Sagot, 74160 Beaumont, France

CategorySingle shareholder

Voting rights acquired9.89%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAHBA00016

Source: SIX Exchange Regulation · Publication date: 14.11.2017

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open